Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organogenesis Holdings Inc. - Class A
(NQ:
ORGO
)
3.730
-0.010 (-0.27%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Organogenesis Holdings Inc. - Class A
< Previous
1
2
3
4
5
6
Next >
Organogenesis Holdings Earnings Perspective: Return On Capital Employed
↗
March 07, 2022
According to Benzinga Pro, during Q4, Organogenesis Holdings (NASDAQ:ORGO) earned $51.70 million, a 311.03% increase from the preceding quarter. Organogenesis Holdings also posted...
Via
Benzinga
68 Biggest Movers From Yesterday
↗
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
Earnings Scheduled For March 1, 2022
↗
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
↗
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 02, 2022
Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a...
Via
Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
↗
March 02, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported...
Via
Benzinga
Mid-Day Market Update: Nasdaq Surges 150 Points; US Crude Oil Inventories Fall By 2.6M Barrels
↗
March 02, 2022
U.S. stocks extended gains midway through trading, with the Nasdaq index jumping 150 points on Wednesday. The Dow traded up 1.71% to 33,865.43 while the NASDAQ rose 1.11% to 13,...
Via
Benzinga
Mid-Morning Market Update: U.S. Stocks Mixed; Dollar Tree Reports Mixed Q4 Results
↗
March 02, 2022
U.S. stocks opened mixed this morning, with the Dow Jones adding more than 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.66% to 33,513.04...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
March 02, 2022
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...
Via
Benzinga
Organogenesis' Q4 Profit Jumps More than 150% To $54M, Issues Solid FY22 Guidance
↗
March 02, 2022
Organogenesis Holdings Inc's (NASDAQ: ORGO) Q4 FY21 sales increased 20% Y/Y to $128.6 million, beating the consensus of $124.70 million. The increase in net revenue...
Via
Benzinga
Recap: Organogenesis Holdings Q4 Earnings
↗
March 01, 2022
Organogenesis Holdings (NASDAQ:ORGO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 01, 2022
Gainers Organogenesis Holdings (NASDAQ:ORGO
Via
Benzinga
A Preview Of Organogenesis Holdings's Earnings
↗
February 28, 2022
Organogenesis Holdings (NASDAQ:ORGO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement....
Via
Benzinga
4 Stocks Insiders Are Buying
↗
November 22, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
Organogenesis Holdings Inc (ORGO) Q3 2021 Earnings Call Transcript
↗
November 10, 2021
ORGO earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
45 Biggest Movers From Yesterday
↗
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
↗
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Mid-Afternoon Market Update: R. R. Donnelley & Sons Surges Following Buyout Offer; Columbia Banking System Shares Slide
↗
October 12, 2021
Toward the end of trading Tuesday, the Dow traded down 0.13% to 34,450.01 while the NASDAQ rose 0.01% to 14,486.37. The S&P also fell, dropping 0.10% to 4,356.92. The U.S....
Via
Benzinga
Topics
Stocks
Mid-Day Market Update: Dow Falls 60 Points; Nutriband Shares Spike Higher
↗
October 12, 2021
Midway through trading Tuesday, the Dow traded down 0.18% to 34,434.80 while the NASDAQ fell 0.14% to 14,466.15. The S&P also fell, dropping 0.19% to 4,352.77. The U.S. has...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 12, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
↗
October 12, 2021
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after...
Via
Benzinga
Organogenesis Holdings Earnings Perspective: Return On Capital Employed
↗
September 17, 2021
According to Benzinga Pro, during Q2, Organogenesis Holdings (NASDAQ:ORGO) earned $23.59 million, a 86.96% increase from the preceding quarter. Organogenesis Holdings also posted...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 13, 2021
Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million...
Via
Benzinga
Organogenesis Q2 Earnings Beat Expectations; Sales Jump 79%; Raises FY21 Sales Outlook
↗
August 10, 2021
Organogenesis Holdings Inc (NASDAQ: ORGO) Q2 revenues increased 79% Y/Y to $123.2 million, edging out analysts' average expectation of $107.30 million. The increase...
Via
Benzinga
Topics
Earnings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 10, 2021
Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5...
Via
Benzinga
Organogenesis Holdings Inc (ORGO) Q2 2021 Earnings Call Transcript
↗
August 10, 2021
ORGO earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
↗
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Organogenesis Holdings: Q2 Earnings Insights
↗
August 09, 2021
Shares of Organogenesis Holdings (NASDAQ:ORGO) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year over...
Via
Benzinga
Organogenesis Holdings Insights: Return On Capital Employed
↗
June 24, 2021
Organogenesis Holdings (NASDAQ:ORGO) posted Q1 earnings of $12.62 million, an increase from Q4 of 42.05%. Sales dropped to $102.55 million, a 3.98% decrease between quarters. In...
Via
Benzinga
Earnings Scheduled For August 9, 2021
↗
August 09, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today